Geneviève Dubuc

1.4k total citations · 1 hit paper
13 papers, 1.1k citations indexed

About

Geneviève Dubuc is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Geneviève Dubuc has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 4 papers in Epidemiology and 4 papers in Hepatology. Recurrent topics in Geneviève Dubuc's work include Lipoproteins and Cardiovascular Health (9 papers), Hepatitis C virus research (4 papers) and Pharmaceutical Economics and Policy (3 papers). Geneviève Dubuc is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Hepatitis C virus research (4 papers) and Pharmaceutical Economics and Policy (3 papers). Geneviève Dubuc collaborates with scholars based in Canada, France and United Kingdom. Geneviève Dubuc's co-authors include Jean Davignon, Nabil G. Seidah, Lise Bernier, Annik Prat, Ann Chamberland, Hanny Wassef, Michel J. Tremblay, Alexis Baass, Jennifer O’Loughlin and Marie Lambert and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Hepatology and Journal of Lipid Research.

In The Last Decade

Geneviève Dubuc

12 papers receiving 1.1k citations

Hit Papers

Statins Upregulate PCSK9 ... 2004 2026 2011 2018 2004 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Statins Upregulate PCSK9 , the Gene Encoding the Proprotein Convertase Neural Apoptosis-Regulated Convertase-1 Implicated in Familial Hypercholesterolemia
    2004 518 citations Geneviève Dubuc, Ann Chamberland et al. Arteriosclerosis Thrombosis and Vascular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geneviève Dubuc Canada 9 990 253 200 165 160 13 1.1k
Jason S. Troutt United States 18 1.2k 1.2× 253 1.0× 197 1.0× 206 1.2× 232 1.4× 26 1.6k
David E. Curtis United States 4 929 0.9× 441 1.7× 219 1.1× 127 0.8× 156 1.0× 4 1.3k
Hanny Wassef Canada 13 624 0.6× 250 1.0× 152 0.8× 94 0.6× 120 0.8× 17 876
Anna Roubtsova Canada 11 608 0.6× 199 0.8× 137 0.7× 67 0.4× 143 0.9× 17 786
Roland P.T. Troquay Netherlands 5 568 0.6× 225 0.9× 148 0.7× 80 0.5× 107 0.7× 6 820
Delphine Allard France 11 695 0.7× 624 2.5× 223 1.1× 109 0.7× 153 1.0× 17 1.4k
Ilaria Giunzioni United States 11 520 0.5× 147 0.6× 128 0.6× 62 0.4× 256 1.6× 13 733
Chiara Ricci Italy 11 427 0.4× 187 0.7× 99 0.5× 62 0.4× 180 1.1× 18 751
Ashley Brooks United Kingdom 8 377 0.4× 370 1.5× 119 0.6× 56 0.3× 100 0.6× 12 927
Thilina Dewpura Canada 6 500 0.5× 127 0.5× 98 0.5× 79 0.5× 76 0.5× 7 561

Countries citing papers authored by Geneviève Dubuc

Since Specialization
Citations

This map shows the geographic impact of Geneviève Dubuc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geneviève Dubuc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geneviève Dubuc more than expected).

Fields of papers citing papers by Geneviève Dubuc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geneviève Dubuc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geneviève Dubuc. The network helps show where Geneviève Dubuc may publish in the future.

Co-authorship network of co-authors of Geneviève Dubuc

This figure shows the co-authorship network connecting the top 25 collaborators of Geneviève Dubuc. A scholar is included among the top collaborators of Geneviève Dubuc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geneviève Dubuc. Geneviève Dubuc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Awan, Zuhier, Geneviève Dubuc, May Faraj, et al.. (2014). The effect of insulin on circulating PCSK9 in postmenopausal obese women. Clinical Biochemistry. 47(12). 1033–1039. 47 indexed citations
2.
Bridge, Simon H., David Sheridan, Daniel J. Felmlee, et al.. (2014). PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism. Journal of Hepatology. 62(4). 763–770. 33 indexed citations
3.
McCarville, Joseph, et al.. (2011). 1237 NO RESISTANCE TO IDX184 WAS DETECTED IN 3-DAY AND 14-DAY CLINICAL STUDIES OF IDX184 IN GENOTYPE 1-INFECTED HCV SUBJECTS. Journal of Hepatology. 54. S488–S489. 5 indexed citations
4.
Davignon, Jean, Geneviève Dubuc, & Nabil G. Seidah. (2010). The Influence of PCSK9 Polymorphisms on Serum Low-Density Lipoprotein Cholesterol and Risk of Atherosclerosis. Current Atherosclerosis Reports. 12(5). 308–315. 61 indexed citations
5.
Bartlett, K., Daniel J. Felmlee, Simon H. Bridge, et al.. (2010). 1078 HYPOCHOLESTEROLAEMIA IN CHRONIC HEPATITIS C GENOTYPE 3 INFECTION IS DUE TO BOTH REDUCED CHOLESTEROL PRODUCTION AND INCREASED LDL CLEARANCE. Journal of Hepatology. 52. S417–S417. 1 indexed citations
6.
Sheridan, David, K. Bartlett, Daniel J. Felmlee, et al.. (2010). Hypocholesterolaemia in chronic Hepatitis C virus (HCV) infection – Reduced production or increased LDL clearance?. Atherosclerosis. 213(1). e4–e4.
7.
Dubuc, Geneviève, Michel J. Tremblay, Guillaume Paré, et al.. (2009). A new method for measurement of total plasma PCSK9: clinical applications. Journal of Lipid Research. 51(1). 140–149. 190 indexed citations
8.
Baass, Alexis, Geneviève Dubuc, Michel J. Tremblay, et al.. (2009). Plasma PCSK9 Is Associated with Age, Sex, and Multiple Metabolic Markers in a Population-Based Sample of Children and Adolescents. Clinical Chemistry. 55(9). 1637–1645. 176 indexed citations
9.
Davignon, Jean & Geneviève Dubuc. (2009). Statins and ezetimibe modulate plasma proprotein convertase subtilisin kexin-9 (PCSK9) levels.. PubMed. 120. 163–73. 60 indexed citations
10.
Abifadel, Marianne, L. Bernier, Geneviève Dubuc, et al.. (2008). A PCSK9 variant and familial combined hyperlipidaemia. Journal of Medical Genetics. 45(12). 780–786. 38 indexed citations
11.
Dubuc, Geneviève, et al.. (2004). Post-transcriptional regulation of apoC-I synthesis and secretion in human HepG2 cells. Atherosclerosis. 178(2). 257–264. 6 indexed citations
12.
Dubuc, Geneviève, Ann Chamberland, Hanny Wassef, et al.. (2004). Statins Upregulate PCSK9 , the Gene Encoding the Proprotein Convertase Neural Apoptosis-Regulated Convertase-1 Implicated in Familial Hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology. 24(8). 1454–1459. 518 indexed citations breakdown →
13.
Zhou, Xiaolei, et al.. (2004). 452 Clinical pharmacokinetics of telbivudine, a potent antiviral for hepatitis B, in subjects with impaired hepatic or renal function. Journal of Hepatology. 40. 134–134. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason S. Troutt Breakdown of academic impact, for papers by David E. Curtis Breakdown of academic impact, for papers by Hanny Wassef Breakdown of academic impact, for papers by Anna Roubtsova Breakdown of academic impact, for papers by Roland P.T. Troquay Breakdown of academic impact, for papers by Delphine Allard Breakdown of academic impact, for papers by Ilaria Giunzioni Breakdown of academic impact, for papers by Chiara Ricci Breakdown of academic impact, for papers by Ashley Brooks Breakdown of academic impact, for papers by Thilina Dewpura
Rankless by CCL
2026